COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,317 Articles (22,772 medRxiv, 8,545 bioRxiv)

Most recent first Previous |  Page 131: Articles 1301-1310  | Next

Evaluating the impact of COVID-19 on the HIV epidemic among men who have sex with men in Australia: A modelling study
Weng, R., Kwon, J. A., Hammoud, M., Clifton, B., Scott, N., McGregor, S., Gray, R. T.
10.1101/2024.12.15.24318054 — Posted: 2024-12-16
Change in mental health trends in Scotland, UK pre- and post-COVID-19
Cooke, E. A., Lemanska, A., Thomas, S. A.
10.1101/2024.12.16.24319095 — Posted: 2024-12-16
Highly recurrent multi-nucleotide mutations in SARS-CoV-2
De Maio, N., Smith, K., Turakhia, Y., Goldman, N.
10.1101/2024.12.14.628346 — Posted: 2024-12-16
A novel SARS-CoV-2-derived infectious vector system
Elfayres, G., Xiao, Y., Pan, Q., Liang, C., Barbeau, B., Berthoux, L.
10.1101/2024.12.16.628561 — Posted: 2024-12-16
Hamsters with long Covid exhibits a neurodegenerative signature in the brainstem
Coleon, A., Larrous, F., Kergoat, L., Tichit, M., Hardy, D., Obadia, T., Kornobis, E., Bourhy, H., de Melo, G. D.
10.1101/2024.12.16.628627 — Posted: 2024-12-16
ConvMut: A Web tool to analyze viral convergent mutations along phylogenies
Bernasconi, A., Fanfoni, E., Alfonsi, T., Focosi, D.
10.1101/2024.12.16.628620 — Posted: 2024-12-16
Safety, tolerability and clinical effects of BC007 on fatigue and quality of life in patients with post-COVID syndrome (reCOVer): a prospective, exploratory, randomised , placebo-controlled, double-blind, crossover phase IIa clinical trial
Hohberger, B., Ganslmayer, M., Harrer, T., Kruse, F., Maas, S., Borst, T., Heimke-Brinck, R., Stog, A., Knauer, T., Ruehl, E., Zeisberg, V., Skornia, A., Bartsch, A., Stroebel, A., Wytopil, M., Merkel, C., Hofmann, S., Schmidt, K. G., Lakatos, P., Schottenhamml, J., Herrmann, M., Mardin, C., Rech, J.
10.1101/2024.12.13.24318856 — Posted: 2024-12-14
Cost-utility analysis of current COVID-19 vaccination program recommendations in Canada
Simmons, A. E., Miranda, R. N., Li, M. W. Z., Gebretekle, G. B., Xi, M., Salvadori, M. I., Warshawsky, B., Wong, E., Ximenes, R., Andrew, M. K., Wilson, S., Tunis, M., Tuite, A. R.
10.1101/2024.12.13.24318988 — Posted: 2024-12-14
Evaluation of T Cell Immune Memory Response after Sinopharm (BBIBP-CorV), Gam-COVID-Vac (Sputnik-V), and Heterologous Sputnik-V/mRNA-1273 (Moderna) COVID-19 Vaccination Schemes against Different SARS-CoV-2 Variants.
Pereson, M. J., Badano, M. N., Sabbione, F., Keitelman, I., Aloisi, N., Fink, S., Amaya, L., Garcia, G., Martinez, A., Di Lello, F. A., Bare, P.
10.1101/2024.12.13.24318016 — Posted: 2024-12-14
Subjective experience of women with childbirth in hospitals after COVID-19 outbreak: Insights from Babies Born Better survey
Greskovicova, K., Nemcova, M., Sikova, T.
10.1101/2024.12.12.24318966 — Posted: 2024-12-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).